Adult Hodgkin's Lymphoma Clinical Trials

• Rituximab in Treating Patients With Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003820 - Active, not recruiting
  stage I adult Hodgkin's lymphoma; stage II adult Hodgkin's lymphoma; stage III adult Hodgkin's lymphoma; stage IV adult Hodgkin's lymphoma; ...
  
• Bortezomib in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00082966 - Recruiting
  recurrent adult Hodgkin's lymphoma; adult nodular sclerosis Hodgkin's lymphoma; adult mixed cellularity Hodgkin's lymphoma; ...
  
• SB-715992 in Treating Patients With Metastatic or Unresectable Solid Tumors or Hodgkin's or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00101244 - Active, not recruiting
  adult Hodgkin's lymphoma; adult lymphomatoid granulomatosis; adult non-Hodgkin's lymphoma; adult solid tumor; ...
  
• Combination Chemotherapy Plus Low-Dose Radiation Therapy in Treating Patients With Stage I or Stage IIA Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00026208 - Recruiting
  stage I adult Hodgkin's lymphoma; stage II adult Hodgkin's lymphoma; adult nodular sclerosis Hodgkin's lymphoma; ...
  
• Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00005584 - Active, not recruiting
  stage I adult Hodgkin's lymphoma; stage II adult Hodgkin's lymphoma; adult lymphocyte predominant Hodgkin's lymphoma
  
• Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00049595 - Recruiting
  adult lymphocyte depletion Hodgkin's lymphoma; adult mixed cellularity Hodgkin's lymphoma; adult nodular sclerosis Hodgkin's lymphoma; ...
  
• Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00002522 - Active, not recruiting
  stage I adult Hodgkin's lymphoma; stage II adult Hodgkin's lymphoma; stage III adult Hodgkin's lymphoma; stage IV adult Hodgkin's lymphoma; ...
  
• 10-Propargyl-10-Deazaaminopterin in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00052442 - Active, not recruiting
  adult Hodgkin's lymphoma; adult non-Hodgkin's lymphoma
  
• Long-Term Effects of Iodine I131 Tositumomab and Autologous Bone Marrow or Stem Cell Transplantation in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00098566 - Active, not recruiting
  adult lymphomatoid granulomatosis; adult non-Hodgkin's lymphoma; indolent or aggressive adult non-Hodgkin's lymphoma; Quality of Life
  
• Reduced-Intensity Regimen Before Allogeneic Bone Marrow Transplantation in Treating Patients With Relapsed Non-Hodgkin's or Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00057954 - Active, not recruiting
  adult Hodgkin's lymphoma; adult T-cell leukemia and lymphoma; adult non-Hodgkin's lymphoma; anaplastic large cell lymphoma; ...
  
• Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage I or Stage II Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00086801 - Active, not recruiting
  stage I adult Hodgkin's lymphoma; stage II adult Hodgkin's lymphoma
  
• Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00002715 - Active, not recruiting
  adult Hodgkin's lymphoma
  
• Filgrastim and Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00005985 - Active, not recruiting
  Hodgkin's lymphoma; adult T-cell leukemia and lymphoma; Non-Hodgkin's Lymphoma
  
• Pegfilgrastim Compared With Filgrastim To Increase Peripheral Stem Cells Before Autologous Stem Cell Transplantation in Treating Patients With Lymphoma
  ClinicalTrials.gov Identifier: NCT00060229 - Active, not recruiting
  adult Hodgkin's lymphoma; adult non-Hodgkin's lymphoma; Cutaneous T-Cell Lymphoma
  
• Tipifarnib in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00082888 - Recruiting
  adult non-Hodgkin's lymphoma; anaplastic large cell lymphoma; Chronic Lymphocytic Leukemia; indolent or aggressive adult non-Hodgkin's lymphoma; ...
  
• Vinblastine, Cyclophosphamide, Procarbazine, Prednisolone, Etoposide, Mitoxantrone, and Bleomycin in Treating Older Patients With Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00079105 - Recruiting
  stage I adult Hodgkin's lymphoma; stage II adult Hodgkin's lymphoma; stage III adult Hodgkin's lymphoma; stage IV adult Hodgkin's lymphoma
  
• Omeprazole and Bortezomib in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00107302 - Recruiting
  adult lymphomatoid granulomatosis; adult non-Hodgkin's lymphoma; adult solid tumor; indolent or aggressive adult non-Hodgkin's lymphoma
  
• Bryostatin 1 Plus Vincristine in Treating Patients With Progressive or Relapsed Non-Hodgkin's Lymphoma After Bone Marrow or Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00058305 - Active, not recruiting
  adult non-Hodgkin's lymphoma
  
• Vaccine Therapy in Treating Patients With Relapsed Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00002821 - Recruiting
  recurrent adult Hodgkin's lymphoma; recurrent/refractory childhood Hodgkin's lymphoma
  
• Combination Chemotherapy Plus Filgrastim With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00028717 - Active, not recruiting
  adult diffuse large cell lymphoma; adult non-Hodgkin's lymphoma; grade 3 follicular lymphoma; Mantle Cell Lymphoma
  
• Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00041210 - Recruiting
  adult Hodgkin's lymphoma
  
• Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003389 - Active, not recruiting
  adult Hodgkin's lymphoma
  
• Thalidomide in Treating Patients With Asymptomatic, Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00052416 - Active, not recruiting
  adult non-Hodgkin's lymphoma
  
• Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease
  ClinicalTrials.gov Identifier: NCT00005613 - Active, not recruiting
  recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent adult diffuse small cleaved cell lymphoma; ...
  
• Combination Chemotherapy With or Without Etoposide in Treating Older Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00060385 - Active, not recruiting
  adult T-cell leukemia and lymphoma; Cutaneous T-Cell Lymphoma; Non-Hodgkin's Lymphoma
  
• Bortezomib in Treating Patients With Lymphoproliferative Disorders
  ClinicalTrials.gov Identifier: NCT00023764 - Recruiting
  adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; indolent or aggressive adult non-Hodgkin's lymphoma
  
• Combination Chemotherapy in Treating Patients With Hodgkin's Disease or Non-Hodgkin's Lymphoma That Has Not Responded to Previous Treatment
  ClinicalTrials.gov Identifier: NCT00014209 - Active, not recruiting
  recurrent grade III follicular large cell lymphoma; recurrent adult immunoblastic large cell lymphoma; ...
  
• Combination Chemotherapy in Treating Patients With Hodgkin's Disease and HIV Infection
  ClinicalTrials.gov Identifier: NCT00003262 - Active, not recruiting
  stage II adult Hodgkin's disease; AIDS-related peripheral/systemic lymphoma; stage III adult Hodgkin's disease; stage IV adult Hodgkin's disease; ...
  
• Autologous Cytotoxic T-Lymphocytes in Treating Patients With Relapsed Epstein-Barr Virus-Associated Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00070226 - Recruiting
  recurrent adult Hodgkin's lymphoma; recurrent/refractory childhood Hodgkin's lymphoma; primary central nervous system lymphoma; ...
  
• VEGF Trap in Treating Patients With Solid Tumors or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00045266 - Active, not recruiting
  adult non-Hodgkin's lymphoma; adult solid tumor
  
• CCI-779 in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00084474 - Recruiting
  adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; indolent or aggressive adult non-Hodgkin's lymphoma
  
• Bortezomib and Fludarabine in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00068315 - Recruiting
  adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; indolent or aggressive adult non-Hodgkin's lymphoma
  
• Peripheral Stem Cell Transplantation Following Radiation Therapy in Treating Patients With Hodgkin's Disease or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00004171 - Active, not recruiting
  recurrent adult diffuse small cleaved cell lymphoma; recurrent grade III follicular large cell lymphoma; ...
  
• Iodine I 131 Tositumomab and Fludarabine in Treating Older Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00110071 - Recruiting
  adult non-Hodgkin's lymphoma; indolent or aggressive adult non-Hodgkin's lymphoma
  
• Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00053768 - Active, not recruiting
  adult non-Hodgkin's lymphoma
  
• Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00002552 - Active, not recruiting
  recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent adult diffuse small cleaved cell lymphoma; ...
  
• Monoclonal Antibody Therapy and Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00017381 - Recruiting
  adult non-Hodgkin's lymphoma; indolent or aggressive adult non-Hodgkin's lymphoma
  
• Combination Chemotherapy Plus Rituximab in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00007865 - Active, not recruiting
  adult non-Hodgkin's lymphoma
  
• Chemotherapy Plus Radiation Therapy in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003631 - Active, not recruiting
  recurrent adult Hodgkin's lymphoma; recurrent/refractory childhood Hodgkin's lymphoma
  
• Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Other B-cell Cancers
  ClinicalTrials.gov Identifier: NCT00003658 - Active, not recruiting
  adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; indolent or aggressive adult non-Hodgkin's lymphoma
  
• Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00002461 - Active, not recruiting
  Lymphocytic Lymphoma; Hodgkin's Disease; Non-Hodgkin's Lymphoma
  
• Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00002742 - Completed
  adult non-Hodgkin's lymphoma; Myeloproliferative Disorders; adult Hodgkin's disease; childhood non-Hodgkin's lymphoma; plasma cell neoplasm; Leukemia; ...
  
• Interferon alfa-2b Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non- Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003924 - Active, not recruiting
  recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent adult diffuse small cleaved cell lymphoma; ...
  
• Oblimersen and Rituximab in Treating Patients With Recurrent Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00054639 - Active, not recruiting
  adult non-Hodgkin's lymphoma
  
• Bortezomib and Flavopiridol in Treating Patients With Recurrent or Refractory Indolent B-Cell Neoplasms
  ClinicalTrials.gov Identifier: NCT00082784 - Recruiting
  adult non-Hodgkin's lymphoma; indolent or aggressive adult non-Hodgkin's lymphoma; refractory plasma cell neoplasm
  
• Biological Therapy Plus Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00040950 - Active, not recruiting
  adult non-Hodgkin's lymphoma
  
• Motexafin Gadolinium, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Stage II, Stage III, or Stage IV Relapsed or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00089284 - Recruiting
  adult non-Hodgkin's lymphoma; indolent or aggressive adult non-Hodgkin's lymphoma
  
• Bendamustine in Treating Patients With Rituximab-Refractory Indolent B-Cell Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00085033 - Completed
  adult non-Hodgkin's lymphoma; indolent or aggressive adult non-Hodgkin's lymphoma
  
• Pegfilgrastim in Treating Neutropenia After Chemotherapy in Patients With Mantle Cell or Diffuse Large B-Cell Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00066833 - Recruiting
  adult diffuse large cell lymphoma; adult non-Hodgkin's lymphoma; Mantle Cell Lymphoma; Neutropenia
  
• Radiation Therapy and Cyclophosphamide Plus Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00004908 - Active, not recruiting
  recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent adult diffuse small cleaved cell lymphoma; ...
  
• Radiolabeled Monoclonal Antibody Therapy in Treating Adult Patients Who Have Recurrent Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00019305 - Recruiting
  Lymphoma; Radiation Toxicity
  
• Combination Chemotherapy in Treating Children With Refractory or Relapsed Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00006760 - Active, not recruiting
  recurrent/refractory childhood Hodgkin's lymphoma; childhood lymphocyte predominant Hodgkin's lymphoma; ...
  
• Antineoplaston Therapy in Treating Patients With Recurrent or Refractory High-Grade Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003501 - Active, not recruiting
  adult Burkitt's lymphoma; adult immunoblastic large cell lymphoma; adult lymphoblastic lymphoma
  
• Antineoplaston Therapy in Treating Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003498 - Recruiting
  adult non-Hodgkin's lymphoma
  
• Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00052936 - Recruiting
  adult T-cell leukemia and lymphoma; anaplastic large cell lymphoma; angioimmunoblastic T-cell lymphoma; Non-Hodgkin's Lymphoma
  
• Positron Emission Tomography Using Fludeoxyglucose F 18 in Predicting Response to Treatment in Patients Who Are Receiving Rituximab and Combination Chemotherapy for Newly Diagnosed Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00110006 - Recruiting
  adult diffuse large cell lymphoma; adult non-Hodgkin's lymphoma; anaplastic large cell lymphoma; grade 3 follicular lymphoma; Mantle Cell Lymphoma
  
• Combination Chemotherapy in Treating Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma Who Have Not Responded to Anthracycline-Containing Combination Chemotherapy
  ClinicalTrials.gov Identifier: NCT00002488 - Active, not recruiting
  recurrent adult lymphoblastic lymphoma; recurrent adult immunoblastic large cell lymphoma; recurrent adult diffuse mixed cell lymphoma; ...
  
• MDX-060 Monoclonal Antibody in Treating Patients With Refractory or Relapsed Lymphoma
  ClinicalTrials.gov Identifier: NCT00059995 - Active, not recruiting
  recurrent adult Hodgkin's lymphoma; recurrent/refractory childhood Hodgkin's lymphoma; anaplastic large cell lymphoma; ...
  
• Combination Chemotherapy and Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00057772 - Recruiting
  grade 1 follicular lymphoma; grade 2 follicular lymphoma; indolent, adult non-Hodgkin's lymphoma; marginal zone lymphoma; Small Lymphocytic Lymphoma
  
• 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00004075 - Completed
  adult Hodgkin's lymphoma; adult T-cell leukemia and lymphoma; adult non-Hodgkin's lymphoma; adult solid tumor; Cutaneous T-Cell Lymphoma; ...
  
• Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Disease
  ClinicalTrials.gov Identifier: NCT00003421 - Active, not recruiting
  stage II adult Hodgkin's disease; stage III adult Hodgkin's disease; stage IV adult Hodgkin's disease; stage I adult Hodgkin's disease
  
• MGCD0103 Administered in Combination With Azacitidine (Vidaza®) to Subjects With Relapsed or Refractory Hodgkin's or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00543582 - Recruiting
  Hodgkin's Lymphoma; Non-Hodgkin's Lymphoma (Follicular or Large Diffuse B-Cell Lymphoma)
  
• Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00070304 - Active, not recruiting
  recurrent/refractory childhood Hodgkin's lymphoma; childhood lymphocyte predominant Hodgkin's lymphoma; ...
  
• Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With B-cell Non-Hodgkin's Lymphoma That Has Relapsed Following Peripheral Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00003963 - Active, not recruiting
  Waldenstrom's Macroglobulinemia; adult non-Hodgkin's lymphoma
  
• Liposomal Vincristine in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00006383 - Active, not recruiting
  recurrent adult immunoblastic large cell lymphoma; recurrent adult T-cell leukemia/lymphoma; recurrent adult diffuse large cell lymphoma; ...
  
• Bortezomib and Ganciclovir in Treating Patients With Relapsed or Refractory Epstein Barr Virus-Positive Lymphoma
  ClinicalTrials.gov Identifier: NCT00093704 - Recruiting
  recurrent adult Hodgkin's lymphoma; recurrent adult Burkitt's lymphoma; post-transplant lymphoproliferative disorder; ...
  
• Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Aggressive Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003815 - Active, not recruiting
  adult non-Hodgkin's lymphoma
  
• FR901228 in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00042822 - Active, not recruiting
  adult acute myeloid leukemia; adult non-Hodgkin's lymphoma; atypical chronic myeloid leukemia; ...
  
• Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Radiation Therapy Followed By Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00070018 - Recruiting
  adult Burkitt's lymphoma; adult diffuse large cell lymphoma; adult non-Hodgkin's lymphoma; anaplastic large cell lymphoma; Mantle Cell Lymphoma
  
• Combination Chemotherapy in Treating Older Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00039351 - Active, not recruiting
  stage I adult diffuse large cell lymphoma; stage III adult diffuse large cell lymphoma; stage IV adult diffuse large cell lymphoma; ...
  
• Epirubicin and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00062296 - Active, not recruiting
  adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia
  
• Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00006373 - Completed
  adult Hodgkin's lymphoma; adult non-Hodgkin's lymphoma
  
• Combination Chemotherapy and Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00002521 - Active, not recruiting
  adult Burkitt's lymphoma; adult diffuse large cell lymphoma; adult diffuse mixed cell lymphoma; adult diffuse small cleaved cell lymphoma; ...
  
• Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00025636 - Active, not recruiting
  recurrent adult Hodgkin's lymphoma
  
• Effect of Rituximab on Immunological Recall Response to Specific Antigens in the Treatment of Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00090038 - Active, not recruiting
  Non-Hodgkin's Lymphoma
  
• Radiation Therapy and Chemotherapy in Treating Patients With Hodgkin's Disease
  ClinicalTrials.gov Identifier: NCT00002561 - Active, not recruiting
  adult lymphocyte predominant Hodgkin's disease; adult lymphocyte depletion Hodgkin's disease; adult mixed cellularity Hodgkin's disease; ...
  
• BAY 59-8862 in Treating Patients With Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00039156 - Active, not recruiting
  recurrent grade III follicular large cell lymphoma; recurrent adult diffuse mixed cell lymphoma; recurrent adult diffuse large cell lymphoma; ...
  
• Radiolabeled Monoclonal Antibody Plus Rituximab With and Without Filgrastim and Interleukin-11 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00012298 - Recruiting
  grade 1 follicular lymphoma; grade 2 follicular lymphoma; grade 3 follicular lymphoma; indolent, adult non-Hodgkin's lymphoma; marginal zone lymphoma; ...
  
• Combination Chemotherapy With or Without Radiation Therapy and Peripheral Stem Cell Transplantation in Treating Children With Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00025064 - Active, not recruiting
  stage II childhood Hodgkin's lymphoma; stage I childhood Hodgkin's lymphoma; stage III childhood Hodgkin's lymphoma; ...
  
• Pixantrone or Other Chemotherapy Drugs in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00101049 - Recruiting
  adult diffuse large cell lymphoma; adult diffuse mixed cell lymphoma; adult immunoblastic large cell lymphoma; anaplastic large cell lymphoma; ...
  
• Combination Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00002481 - Active, not recruiting
  recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent adult diffuse small cleaved cell lymphoma; ...
  
• Antineoplaston Therapy in Treating Patients With Refractory or Recurrent Intermediate-Grade Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003500 - Active, not recruiting
  adult diffuse large cell lymphoma; adult diffuse mixed cell lymphoma; adult diffuse small cleaved cell lymphoma; grade 3 follicular lymphoma
  
• BMS-247550 in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00058019 - Recruiting
  recurrent grade 3 follicular lymphoma; recurrent adult diffuse large cell lymphoma; recurrent adult diffuse mixed cell lymphoma; ...
  
• Allogeneic Epstein Barr Virus-Specific Cytotoxic T-Lymphocytes in Treating Patients With Progressive, Relapsed, or Refractory Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00006100 - Active, not recruiting
  recurrent adult Hodgkin's lymphoma
  
• Ixabepilone in Treating Patients With Relapsed or Refractory Lymphoproliferative Disorders
  ClinicalTrials.gov Identifier: NCT00052572 - Completed
  adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; indolent or aggressive adult non-Hodgkin's lymphoma
  
• Rituximab and Combination Chemotherapy in Treating Older Patients With Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00101010 - Recruiting
  adult non-Hodgkin's lymphoma
  
• Bortezomib in Treating Patients With Advanced Cancer and Liver Dysfunction
  ClinicalTrials.gov Identifier: NCT00091117 - Recruiting
  adult non-Hodgkin's lymphoma; adult primary liver cancer; adult solid tumor
  
• Radiation Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma Who Have Undergone Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00031668 - Active, not recruiting
  recurrent adult diffuse small noncleaved cell/Burkitt's lymphoma; recurrent adult T-cell leukemia/lymphoma; ...
  
• Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00079261 - Active, not recruiting
  adult diffuse large cell lymphoma; adult lymphomatoid granulomatosis; anaplastic large cell lymphoma; angioimmunoblastic T-cell lymphoma; ...
  
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003957 - Active, not recruiting
  recurrent grade III follicular large cell lymphoma; recurrent adult immunoblastic large cell lymphoma; recurrent adult diffuse mixed cell lymphoma; ...
  
• Interleukin-2 or Observation Following Radiation Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00002649 - Active, not recruiting
  adult non-Hodgkin's lymphoma
  
• Cyclophosphamide With or Without Rituximab and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00028665 - Active, not recruiting
  adult non-Hodgkin's lymphoma
  
• Rituximab Plus Interleukin-2 in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00010192 - Active, not recruiting
  adult acute lymphoblastic leukemia; adult non-Hodgkin's lymphoma
  
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003215 - Active, not recruiting
  adult diffuse large cell lymphoma; adult diffuse mixed cell lymphoma; adult immunoblastic large cell lymphoma; anaplastic large cell lymphoma
  
• Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00004192 - Active, not recruiting
  recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent adult diffuse small cleaved cell lymphoma; ...
  
• Treatment of Non-Hodgkin's Lymphoma with 90Y-hLL2 IgG
  ClinicalTrials.gov Identifier: NCT00061425 - Active, not recruiting
  Non-Hodgkin's Lymphoma; Lymphoma, B-Cell
  
• Oblimersen and Gemcitabine in Treating Patients With Advanced Solid Tumor or Lymphoma
  ClinicalTrials.gov Identifier: NCT00060112 - Suspended
  adult Hodgkin's lymphoma; adult T-cell leukemia and lymphoma; adult non-Hodgkin's lymphoma; adult solid tumor; Cutaneous T-Cell Lymphoma
  
• Bevacizumab in Treating Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00016094 - Active, not recruiting
  recurrent adult diffuse large cell lymphoma; recurrent adult Burkitt's lymphoma; recurrent mantle cell lymphoma; anaplastic large cell lymphoma
  
• Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00002494 - Active, not recruiting
  stage I adult diffuse small noncleaved cell/Burkitt's lymphoma; noncontiguous stage II adult diffuse small noncleaved cell/Burkitt's lymphoma; ...
  
• Bryostatin 1 and Rituximab in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00087425 - Completed
  adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; indolent or aggressive adult non-Hodgkin's lymphoma